As part of our strategic collaboration with Johns Hopkins, we are able to showcase, to more individuals, how Kaiser Permanente is a national leader on quality, service, and affordability.
On November 18, Kaiser Permanente participated in the third annual Diabetes Symposium with Johns Hopkins Sibley and Suburban Hospitals. With more than 150 guests in attendance, the event convened area thought leaders to discuss and share best practices for controlling diabetes.
Jaye Noel, MD, chief of Endocrinology for the Mid-Atlantic Permanente Medical Group and Ranganath Muniyappa, MD, clinical researcher at the National Institute of Diabetes and Digestive and Kidney Diseases, presented at the symposium and discussed recommended treatment strategies for people with diabetes and pre-diabetes.
Experts also introduced the attendees to novel therapies including the “bionic Pancreas” and fielded questions from attendees about best practices for controlling diabetes. Health educators were available to interact with attendees after the meeting.
Kaiser Permanente’s involvement with the symposium is another illustration of how our enhanced relationship with Johns Hopkins is helping to advance health care in the region.
